Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
20.81
+0.81 (4.05%)
At close: Aug 7, 2026, 4:00 PM EDT
21.22
+0.41 (1.96%)
After-hours: Aug 7, 2026, 7:34 PM EDT

Xencor Revenue

Xencor had revenue of $51.22M in the quarter ending June 30, 2026, with 17.46% growth. This brings the company's revenue in the last twelve months to $104.97M, down -28.56% year-over-year. In the year 2025, Xencor had annual revenue of $125.58M with 13.65% growth.

Revenue (ttm)
$104.97M
Revenue Growth
-28.56%
P/S Ratio
14.74
Revenue / Employee
$403,742
Employees
260
Market Cap
1.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025125.58M15.08M13.65%
Dec 31, 2024110.49M-64.12M-36.72%
Dec 31, 2023174.62M10.04M6.10%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 201840.60M-5.55M-12.02%
Dec 31, 201746.15M-62.87M-57.67%
Dec 31, 2016109.02M81.26M292.70%
Dec 31, 201527.76M18.24M191.62%
Dec 31, 20149.52M-652.00K-6.41%
Dec 31, 201310.17M648.00K6.80%
Dec 31, 20129.52M2.68M39.06%
Dec 31, 20116.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Innoviva440.00M
Vir Biotechnology303.23M
Maravai LifeSciences Holdings208.78M
Maze Therapeutics20.00M
Absci1.84M
Revenue Rankings